Tau-PET pathology in the subregions of the amygdala and its associations with cognitive performance and neuropsychiatric symptoms in autosomal dominant Alzheimer’s disease

These findings suggest that in autosomal dominant AD, tau accumulation in the amygdala begins early in the basal nucleus, while both the basal and the lateral nuclei are associated with early cognitive deficits and depressive symptoms. The nuclei's differential vulnerability to pathology underscores the importance of investigating tau spread within amygdala-associated networks, relative to the early clinical manifestations of AD. This study reinforces the potential of amygdala tau burden as a valuable biomarker for preclinical AD.

Authors

Institutions

Publication Details

Journal
Alzheimer s Research & Therapy
Published
2025-03-20
DOI
https://doi.org/10.1186/s13195-025-01711-z
Citations
7
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
10.30

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tau-PET pathology in the subregions of the amygdala and its associations with cognitive performance and neuropsychiatric symptoms in autosomal dominant Alzheimer’s disease

Heidi I.L. Jacobs, Reisa Anne Sperling, Zoe B. Rubinstein, Justin S. Sanchez et al.
7 citations
Alzheimer s Research & Therapy
Dementia and Cognitive Impairment Research
10.30
article

Tau-PET pathology in the subregions of the amygdala and its associations with cognitive performance and neuropsychiatric symptoms in autosomal dominant Alzheimer’s disease

Heidi I.L. Jacobs, Reisa Anne Sperling, Zoe B. Rubinstein, Justin S. Sanchez, Daniel Vásquez, Ana Baena, Liliana Ramírez Gómez, Keith Johnson, David Fernando Aguillon, Jennifer R. Gatchel, Jorge Alcina, Yakeel T. Quiroz, Stephanie Langella, Catarina Tristão‐Pereira, Clara Vila‐Castelar, Vincent Malotaux, Cláudia Ramos, Averi Giudicessi, Bing He, Jairo E. Martínez
article en
7 citations

Abstract

These findings suggest that in autosomal dominant AD, tau accumulation in the amygdala begins early in the basal nucleus, while both the basal and the lateral nuclei are associated with early cognitive deficits and depressive symptoms. The nuclei's differential vulnerability to pathology underscores the importance of investigating tau spread within amygdala-associated networks, relative to the early clinical manifestations of AD. This study reinforces the potential of amygdala tau burden as a valuable biomarker for preclinical AD.

Alzheimer s Research & TherapyVol. 17(1)
Boston University (US), Harvard University (US), McLean Hospital (US), Universidad de Antioquia (CO), Massachusetts General Hospital (US)
National Institute on Aging
Openalex Percentile: Top 2%
Dementia and Cognitive Impairment Research
10.30
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.